- Home
- KLTOW vs GRABW Comparison
KLTOW vs GRABW Comparison
Compare KLTOW & GRABW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTOW
- GRABW
- Stock Information
- Founded
- KLTOW N/A
- GRABW 2012
- Country
- KLTOW United States
- GRABW Singapore
- Employees
- KLTOW 3
- GRABW 11267
- Industry
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- GRABW Business Services
- Sector
- KLTOW Health Care
- GRABW Consumer Discretionary
- Exchange
- KLTOW Nasdaq
- GRABW Nasdaq
- Market Cap
- KLTOW N/A
- GRABW N/A
- IPO Year
- KLTOW 2022
- GRABW N/A
- Fundamental
- Price
- KLTOW $0.02
- GRABW $0.33
- Analyst Decision
- KLTOW
- GRABW
- Analyst Count
- KLTOW 0
- GRABW 0
- Target Price
- KLTOW N/A
- GRABW N/A
- AVG Volume (30 Days)
- KLTOW N/A
- GRABW 54.7K
- Earning Date
- KLTOW N/A
- GRABW 02-21-2025
- Dividend Yield
- KLTOW N/A
- GRABW N/A
- EPS Growth
- KLTOW N/A
- GRABW N/A
- EPS
- KLTOW N/A
- GRABW N/A
- Revenue
- KLTOW N/A
- GRABW $2,686,000,000.00
- Revenue This Year
- KLTOW N/A
- GRABW N/A
- Revenue Next Year
- KLTOW N/A
- GRABW N/A
- P/E Ratio
- KLTOW N/A
- GRABW N/A
- Revenue Growth
- KLTOW N/A
- GRABW 21.65
- 52 Week Low
- KLTOW N/A
- GRABW $0.15
- 52 Week High
- KLTOW N/A
- GRABW $0.59
- Technical
- Relative Strength Index (RSI)
- KLTOW N/A
- GRABW 42.67
- Support Level
- KLTOW N/A
- GRABW $0.31
- Resistance Level
- KLTOW N/A
- GRABW $0.39
- Average True Range (ATR)
- KLTOW 0.00
- GRABW 0.06
- MACD
- KLTOW 0.00
- GRABW -0.00
- Stochastic Oscillator
- KLTOW 0.00
- GRABW 20.62
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.